Pain, Erwann;
Snowden, Stuart;
Oddy, Joseph;
Shinhmar, Sonia;
Alhammad, Yousef M. A.;
King, Jason S.;
Müller-Taubenberger, Annette;
Williams, Robin S. B.
Pharmacological inhibition of ENT1 enhances the impact of specific dietary fats on energy metabolism gene expression
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Pharmacological inhibition of ENT1 enhances the impact of specific dietary fats on energy metabolism gene expression
Beteiligte:
Pain, Erwann;
Snowden, Stuart;
Oddy, Joseph;
Shinhmar, Sonia;
Alhammad, Yousef M. A.;
King, Jason S.;
Müller-Taubenberger, Annette;
Williams, Robin S. B.
Erschienen:
Proceedings of the National Academy of Sciences, 2024
Erschienen in:
Proceedings of the National Academy of Sciences, 121 (2024) 36
Sprache:
Englisch
DOI:
10.1073/pnas.2321874121
ISSN:
0027-8424;
1091-6490
Entstehung:
Anmerkungen:
Beschreibung:
Medium chain fatty acids are commonly consumed as part of diets for endurance sports and as medical treatment in ketogenic diets where these diets regulate energy metabolism and increase adenosine levels. However, the role of the equilibrative nucleoside transporter 1 (ENT1), which is responsible for adenosine transport across membranes in this process, is not well understood. Here, we investigate ENT1 activity in controlling the effects of two dietary medium chain fatty acids (decanoic and octanoic acid), employing the tractable model system Dictyostelium. We show that genetic ablation of three ENT1 orthologues unexpectedly improves cell proliferation specifically following decanoic acid treatment. This effect is not caused by increased adenosine levels triggered by both fatty acids in the presence of ENT1 activity. Instead, we show that decanoic acid increases expression of energy-related genes relevant for fatty acid β-oxidation, and that pharmacological inhibition of ENT1 activity leads to an enhanced effect of decanoic acid to increase expression of tricarboxylicacid cycle and oxidative phosphorylation components. Importantly, similar transcriptional changes have been shown in the rat hippocampus during ketogenic diet treatment. We validated these changes by showing enhanced mitochondria load and reduced lipid droplets. Thus, our data show that ENT1 regulates the medium chain fatty acid-induced increase in cellular adenosine levels and the decanoic acid-induced expression of important metabolic enzymes in energy provision, identifying a key role for ENT1 proteins in metabolic effects of medium chain fatty acids.